Por método (em IORT eletrónico, braquiterapia intraoperatória, IORT de alta taxa de dose, IORT de raios X e outros.), tipo de produto (dispositivos de radioterapia intraoperatória, acessórios de radioterapia intraoperatória e software e serviços) (portátil e de bancada) , aplicação ( cancro da mama, tumor cerebral, cancro de cabeça e pescoço, sarcoma de tecidos moles, tumores pediátricos, cancro ginecológico, cancro geniturinário, tumores gastrointestinais superiores e outros tipos de cancro) utilizador final (hospital, centros de cirurgia ambulatória, centro especializado e outros) e canal de distribuição ( concurso direto e vendas a retalho) País (África do Sul, Arábia Saudita, Emirados Árabes Unidos, Egito, Israel e resto do Médio Oriente e África) Tendências e previsões da indústria para 2028
Análise de mercado e insights: Mercado de radioterapia intraoperatória no Médio Oriente e África
Espera-se que o mercado de radioterapia intraoperatória do Médio Oriente e África ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 5,1% no período de previsão de 2021 a 2028 e prevê-se que atinja os 17,31 milhões de dólares até 2028. O aumento da procura de radioterapia intraoperatória na indústria médica é um importante impulsionador que deverá impulsionar o crescimento do mercado de radioterapia intraoperatória no Médio Oriente e em África.
A radioterapia intraoperatória (IORT) é uma técnica que envolve a administração de uma dose elevada de radiação ionizante ao tumor ou ao leito tumoral durante a cirurgia. Envolve a visualização direta do leito tumoral e espaça os tecidos normais do leito tumoral, o que permite a maximização da dose para o tumor, minimizando a dose para os tecidos normais. Assim, a IORT é capaz de fornecer uma dose eficaz total mais elevada ao leito tumoral e facilitar o escalonamento da dose sem aumentar significativamente as complicações do tecido normal e melhorar a relação terapêutica.
Como a radiação IORT é dirigida diretamente ao tumor, a dose pode ser até 2,5 vezes superior a uma dose segura de radiação tradicional. Isto ajuda a evitar que o cancro volte ao mesmo lugar. A IORT demonstrou a sua eficácia numa ampla variedade de tumores e cancros, como o cancro colorretal recorrente, o cancro ginecológico recorrente e os tumores de tecidos moles. Recentemente, surgiu como uma opção de tratamento popular para o cancro da mama selecionado em fase inicial, devido à sua capacidade de completar todo o curso de radioterapia durante a cirurgia.
Os fatores que impulsionam o crescimento do mercado da radioterapia intraoperatória são o aumento da população idosa com mais de 60 anos e o avanço da tecnologia moderna e sofisticada no mercado dos IORT, como a inteligência artificial. Por outro lado, o risco associado à exposição à radiação em doses elevadas, como problemas de pele e fadiga, e os desafios associados ao valor da marca podem restringir o crescimento do mercado. O aumento de estudos de investigação e ensaios clínicos para segurança e eficácia sobre a utilização de IORT no tratamento do cancro e a crescente aplicação de IORT em diversos tratamentos oncológicos, como o cancro da mama e o tumor cerebral, são oportunidades no mercado.
A elevada concorrência entre os principais players desafia o crescimento do mercado como um desafio no crescimento do mercado. Eu
Este relatório de mercado de radioterapia intraoperatória do Médio Oriente e África fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado, aprovações de produtos, estratégias decisões, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado contacte-nos para um Analyst Brief, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.
Médio Oriente e África Âmbito do mercado e dimensão do mercado da radioterapia intraoperatória
O mercado da radioterapia intraoperatória no Médio Oriente e África está segmentado com base no método, produto, tipo, aplicação, utilizador final e canal de distribuição. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.
- Com base no método, o mercado da radioterapia intraoperatória está segmentado em IORT eletrónico, braquiterapia intraoperatória, IORT de alta taxa de dose, IORT de raios X, entre outros. Em 2021, prevê-se que o segmento IORT de raios X domine o mercado devido à maior utilização de IORT de raios X no fornecimento de alta taxa de dose única de raios X.
- Com base no produto, o mercado da radioterapia intraoperatória está segmentado em dispositivos de radioterapia intraoperatória, acessórios de radioterapia intraoperatória e software e serviços. Em 2021, prevê-se que o segmento dos dispositivos de radioterapia intraoperatória domine o mercado da radioterapia intraoperatória, uma vez que é o equipamento mais utilizado para a administração IORT de raios X intraoperatórios.
- Com base no tipo, o mercado da radioterapia intraoperatória está segmentado em portátil e de bancada. Em 2021, espera-se que o segmento portátil domine o mercado, uma vez que pode ser transportado para qualquer lugar e não exige muito esforço.
- On the basis of application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, head & neck cancer, soft tissue sarcoma, pediatric tumors, gynecological cancer, genitourinary cancers, upper gastro-intestinal tumors, and other cancers. In 2021, breast cancer segment is expected to dominate the market due to growing prevalence of breast cancer in women in the region.
- On the basis of end user, the intraoperative radiation therapy market is segmented into hospital, ambulatory surgical centers, specialty centers, and others. In 2021, hospital segment is expected to dominate the market due to growing number of hospitals in the region.
- On the basis of distribution channel, the intraoperative radiation therapy market is segmented into direct tender and retail sales. In 2021, the direct tender segment is expected to dominate the market as it is a quick and easy way to purchase the equipment.
Middle East and Africa Intraoperative radiation therapy Market: Country Level Analysis
The Middle East and Africa intraoperative radiation therapy market is analyzed and market size information is provided by method, product, type, application, end user, and distribution channel as referenced above.
Countries covered in the Middle East and Africa intraoperative radiation therapy market report are South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa
South Africa is dominating the Middle East and Africa intraoperative radiation therapy market with highest CAGR and largest market share due to increase number of technological product launches by the major manufacturers in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa Intraoperative radiation therapy brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising Demand of Intraoperative radiation therapy in Medical Industry
Middle East and Africa intraoperative radiation therapy market also provides you with detailed market analysis for every country growth in industry with sales, components sales, impact of technological development in intraoperative radiation therapy and changes in regulatory scenarios with their support for the intraoperative radiation therapy market. The data is available for historic period 2010-2019.
Competitive Landscape and Middle East and Africa Intraoperative radiation therapy Market Share Analysis
O panorama competitivo do mercado de radioterapia intraoperatória do Médio Oriente e África fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na Índia, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura e amplitude do produto, domínio da aplicação e curva de segurança da tecnologia. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado da radioterapia intraoperatória no Médio Oriente e em África.
Alguns dos principais players que operam no mercado da radioterapia intraoperatória são a IntraOp Medical, Inc., a Ariane Medical Systems Ltd, a Varian Medical Systems, Inc., a Carl Zeiss MEDITECAG, a Eckert & Ziegler. , Sensus Healthcare Inc, iCAD Inc., Elekta AB, SIT - SIT Sordina IORT Technologies SpA, REMEDI Co., Ltd., GMV INNOVATING SOLUTIONS, Brainlab, AG e outros.
O mercado global de radioterapia intraoperatória está fragmentado e os principais players têm utilizado diversas estratégias, tais como colaboração, reconhecimento, acordos e outras para aumentar as suas pegadas no mercado de radioterapia intraoperatória.
Por exemplo,
- Em abril de 2021, a Varian Medical Systems, Inc. assinou um acordo com o Icon Group da Austrália para fornecer 30 aceleradores lineares e software de tratamento associado para combater a carga global do cancro. Isto ajudará a empresa a aumentar o acesso aos cuidados de saúde em áreas regionais e com serviços insuficientes na Austrália e na Ásia.
- Em outubro de 2020, a IntraOp Medical, Inc. e a Universidade de Verona, em Itália, anunciaram a inscrição do primeiro doente no ensaio PancFORT. Isto ajudou a empresa a avançar na ciência e nas evidências clínicas que apoiam o papel da IORT no tratamento desta terrível doença.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION METHOD COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: INDUSTRY INSIGHTS
5.1 THE U.S.
5.2 FRANCE
5.3 GERMANY
5.4 CHINA
5.5 JAPAN
5.6 INDIA
5.7 BRAZIL
5.8 SOUTH AFRICA
6 NEW PRODUCT LAUNCH- MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET
7 REGULATORY FRAMEWORK
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 RISE IN PREVALENCE OF CANCER DISEASES
8.1.2 RISE IN COLLABORATION AND AGREEMENT OF INTRAOPERATIVE RADIATION THERAPY MARKET PLAYERS WITH HOSPITALS AND OTHER MEDICAL SETTINGS
8.1.3 RISE IN GERIATRIC POPULATION THAT ARE MOST VULNERABLE TO CANCER
8.1.4 TECHNOLOGY ADVANCEMENT IN IORT
8.1.5 SUPPORTING REIMBURSEMENT POLICIES FOR CANCER PATIENT
8.2 RESTRAINTS
8.2.1 RISK ASSOCIATED WITH HIGH DOSE RADIATION EXPOSURE
8.2.2 CHALLENGES ASSOCIATED WITH BRAND EQUITY
8.3 OPPORTUNITIES
8.3.1 INCREASE IN THE NUMBER OF CLINICAL TRIALS OVER THE USE OF IORT
8.3.2 INCREASE APPLICATION OF IORT IN VARIOUS CANCER TREATMENT
8.4 CHALLENGES
8.4.1 LACK OF SKILLED ONCOLOGIST
8.4.2 HIGH COMPETITION AMONG KEY PLAYERS
8.4.3 HIGH COST OF IORT TREATMENT
9 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD
9.1 OVERVIEW
9.2 X-RAY IORT
9.3 INTRAOPERATIVE BRACHYTHERAPY
9.4 HIGH DOSE-RATE IORT
9.5 ELECTRON IORT
9.6 OTHERS
10 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT
10.1 OVERVIEW
10.2 INTRAOPERATIVE RADIATION THERAPY DEVICES
10.2.1 X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM
10.2.1.1 X-Ray Brachytherapy System
10.2.1.2 Mobile X-Ray Intraoperative Radiation Therapy System
10.2.1.3 Others
10.2.2 TREATMENT PLANNING SYSTEMS
10.2.3 HDR AFTERLOADERS
10.2.4 ELECTRON BEAM INTRAOPERATIVE RADIATION THERAPY SYSTEM
10.2.5 ACCELERATORS
10.2.6 OTHERS
10.3 INTRAOPERATIVE RADIATION THERAPY ACCESSORIES
10.3.1 APPLICATORS
10.3.1.1 Surface Applicators
10.3.1.2 Needle Applicators
10.3.2 WORKSTATIONS
10.3.3 GENERATORS
10.3.4 FLAT APPLICATORS
10.3.5 OTHERS
10.4 SOFTWARES & SERVICES
11 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE
11.1 OVERVIEW
11.2 PORTABLE
11.3 BENCHTOP
12 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 BREAST CANCER
12.3 GENITOURINARY CANCERS
12.3.1 COLORECTAL CANCER
12.3.2 PROSTATE CANCER
12.3.3 RENAL CANCER
12.3.4 BLADDER CANCER
12.3.5 OTHERS
12.4 SOFT TISSUE SARCOMA
12.5 UPPER GASTRO-INTESTINAL TUMORS
12.5.1 PANCREATIC CANCER
12.5.2 GASTRIC CANCER
12.5.3 OTHERS
12.6 GYNAECOLOGICAL CANCER
12.7 BRAIN TUMOR
12.8 HEAD & NECK CANCER
12.9 PAEDIATRICS TUMORS
12.1 OTHERS CANCER
13 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITAL
13.3 SPECIALTY CENTERS
13.4 AMBULATORY SURGICAL CENTERS
13.5 OTHERS
14 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAIL SALES
15 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION
15.1 MIDDLE EAST AND AFRICA
15.1.1 SOUTH AFRICA
15.1.2 EGYPT
15.1.3 SAUDI ARABIA
15.1.4 ISRAEL
15.1.5 U.A.E.
15.1.6 REST OF MIDDLE EAST AND AFRICA
16 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 VARIAN MEDICAL SYSTEMS INC
18.1.1 COMPANY SNAPSHOT
18.1.2 COMPANY SHARE ANALYSIS
18.1.3 PRODUCT PORTFOLIO
18.1.4 RECENT DEVELOPMENTS
18.2 CARL ZEISS AG
18.2.1 COMPANY SNAPSHOT
18.2.2 COMPANY SHARE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENT
18.3 ECKERT & ZEIGLER
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 ELEKTA AB
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENT
18.5 GMV
18.5.1 COMPANY SNAPSHOT
18.5.2 COMPANY SHARE ANALYSIS
18.5.3 PRODUCT PORTFOLIO
18.5.4 RECENT DEVELOPMENT
18.6 ARIANE MEDICAL SYSTEMS LTD
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENT
18.7 BRAINLAB AG
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENT
18.8 ICAD INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 REVENUE ANALYSIS
18.8.3 PRODUCT PORTFOLIO
18.8.4 RECENT DEVELOPMENTS
18.9 INTRAOP MEDICAL, INC.
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 REMEDI CO., LTD.
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 SENSUS HEALTHCARE
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENT
18.12 SIT - S.I.T. SORDINA IORT TECHNOLOGIES S.P.A.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
Lista de Tabela
LIST OF TABLES
TABLE 1 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN THE U.S.
TABLE 2 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN FRANCE
TABLE 3 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN GERMANY
TABLE 4 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN CHINA
TABLE 5 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN JAPAN
TABLE 6 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN INDIA
TABLE 7 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN BRAZIL
TABLE 8 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN SOUTH AFRICA
TABLE 9 AGING WORLD POPULATION
TABLE 10 UK X RAY DEMAND 2018
TABLE 11 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA X-RAY IORT IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 THE MOST POPULAR X-RAY IORT IS GIVEN IN THE TABLE BELOW:
COMPANY
TABLE 14 MIDDLE EAST AND AFRICA INTRAOPERATIVE BRACHYTHERAPY IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA HIGH DOSE-RATE IORT IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA ELECTRON IORT IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA OTHERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 THE MOST PROMINENT X-RAY DEVICE USED ARE LISTED IN THE TABLE GIVEN BELOW:
TABLE 21 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 THE MOST PROMINENT APPLICATORS AND THEIR USES HAVE BEEN PROVIDED AT THE TABLE BELOW:
TABLE 25 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA SOFTWARES & SERVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 SOME OF THE POPULAR SOFTWARE AND SERVICES FOR CANCER PATIENTS ARE GIVEN BELOW:
TABLE 29 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA PORTABLE IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 COMPANIES THAT PROVIDE PORTABLE INTRAOPERATIVE RADIATION THERAPY DEVICES
TABLE 32 MIDDLE EAST AND AFRICA BENCHTOP IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 MAJOR RESEARCH STUDIES THAT HAVE UTILIZED BENCHTOP IORT DEVICES
TABLE 34 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA BREAST CANCER IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA SOFT TISSUE SARCOMA IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA GYNACOLOGICAL CANCER IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 LIST OF COMMON GYNAECOLOGICAL CANCER
TABLE 43 MIDDLE EAST AND AFRICA BRAIN TUMOR IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA HEAD & NECK CANCER IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA PAEDIATRICS TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 THE OCCURRENCE RATE FOR THE MAJORITY OF PAEDIATRICSS CANCER IN CHILDREN ARE LISTED BELOW:
TABLE 47 MIDDLE EAST AND AFRICA OTHERS CANCER IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA HOSPITAL IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA SPECIALTY CENTERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA OTHERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA DIRECT TENDER IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA RETAIL SALES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028(USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 58 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 59 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 61 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 62 MIDDLE EAST AND AFRICA APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 63 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 64 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 MIDDLE EAST AND AFRICA GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 66 MIDDLE EAST AND AFRICA UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 68 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 69 SOUTH AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 70 SOUTH AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 71 SOUTH AFRICA INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 72 SOUTH AFRICA X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 73 SOUTH AFRICA INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 74 SOUTH AFRICA APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 75 SOUTH AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 76 SOUTH AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 SOUTH AFRICA GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 78 SOUTH AFRICA UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 79 SOUTH AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 80 SOUTH AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 81 EGYPT INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 82 EGYPT INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 83 EGYPT INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 84 EGYPT X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 85 EGYPT INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 86 EGYPT APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 87 EGYPT INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 88 EGYPT INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 89 EGYPT GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 90 EGYPT UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 91 EGYPT INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 92 EGYPT INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 93 SAUDI ARABIA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 94 SAUDI ARABIA INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 95 SAUDI ARABIA INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 96 SAUDI ARABIA X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 97 SAUDI ARABIA INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 98 SAUDI ARABIA APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 99 SAUDI ARABIA INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 100 SAUDI ARABIA INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 101 SAUDI ARABIA GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 102 SAUDI ARABIA UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 103 SAUDI ARABIA INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 104 SAUDI ARABIA INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 105 ISRAEL INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 106 ISRAEL INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 107 ISRAEL INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 108 ISRAEL X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 109 ISRAEL INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 110 ISRAEL APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 111 ISRAEL INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 112 ISRAEL INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 ISRAEL GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 114 ISRAEL UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 115 ISRAEL INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 116 ISRAEL INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 117 U.A.E. INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION)
TABLE 118 U.A.E. INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 119 U.A.E. INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 120 U.A.E. X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 121 U.A.E. INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 122 U.A.E. APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 123 U.A.E. INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 124 U.A.E. INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 125 U.A.E. GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 126 U.A.E. UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 127 U.A.E. INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 128 U.A.E. INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 129 REST OF MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION)
Lista de Figura
LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET : SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET : DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 10 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: SEGMENTATION
FIGURE 11 GROWING PREVALENCE OF CANCER DISEASES IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 INTRAOPERATIVE RADIATION THERAPY DEVICES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET
FIGURE 14 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2020
FIGURE 15 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2020
FIGURE 16 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2020
FIGURE 17 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2020
FIGURE 18 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2020
FIGURE 19 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020
FIGURE 20 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: SNAPSHOT (2020)
FIGURE 21 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: BY COUNTRY (2020)
FIGURE 22 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: BY COUNTRY (2021 & 2028)
FIGURE 23 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: BY COUNTRY (2020 & 2028)
FIGURE 24 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: BY METHOD (2021 & 2028)
FIGURE 25 MIDDLE EAST AND AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET: COMPANY SHARE 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
